Summary Information:
Evogene Ltd Ordinary Shares
NASDAQ:EVGN


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Evogene Ltd Ordinary Shares
Exchange: NASDAQ
Symbol: EVGN
SEC CIK: 0001574565
Phone: 97289311900
13 GAD FEINSTEIN STREET
PARK REHOVOT P.O.B 2100
REHOVOT L3 76121
CEO:
Price when page updated: 0.6246 Date: 2023-11-30
Company Website:
www.evogene.com

_Description: Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.

IPO YEAR:

Sector:
Basic Industries
Industry:
Agricultural Chemicals
ADRTSO:

MarketCap:
25758504.00
Beta:
1.797349224750130
52 Week High:
10.24
52 Week Low:
1.66
52 Week Change:
-0.6122448979591837
Short Interest:

Short Date:

Shares Outstanding:
41164424
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
31 Aug 2022
Float:
0
return on Equity:
-52.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
$834.000k
Gross Profit:

Cash:

Debt:

Institution Percent:
6.50%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
6.11%
Return on Assets:
-37.50%
Return on Capital:

Profit Margin:
-
Price to Sales:
51.99
Price To Book:
1.02
Short Ratio:
1.87
PE Ratio:
0
Employees:
131
1Y Guesstimate
6.790:6.0:6




__The following are links to various summary and news pages for
__Evogene Ltd Ordinary Shares [ EVGN ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30